Suppr超能文献

新型非缺血性心力衰竭相关活性氧化代谢物的影响。

Impact of Reactive Oxidative Metabolites Among New Categories of Nonischemic Heart Failure.

机构信息

Department of Cardiovascular Medicine Faculty of Life Sciences Graduate School of Medical Science and Center for Metabolic Regulation of Healthy Aging (CMHA) Kumamoto University Kumamoto Japan.

出版信息

J Am Heart Assoc. 2021 Apr 6;10(7):e016765. doi: 10.1161/JAHA.120.016765. Epub 2021 Mar 18.

Abstract

Background We investigated the clinical significance of derivatives of reactive oxygen metabolites (DROMs), a new marker of reactive oxygen species, in patients with nonischemic heart failure (HF) and compared them among new categories of HF. Methods and Results We recruited 201 consecutively hospitalized patients with HF and measured DROM under stable conditions. Then, we divided them according to new categories of HF (HF with reduced ejection fraction [EF], HF with midrangeEF, and HF with preserved EF) without coronary artery disease. In subgroup analysis, we followed EF changes in patients with HF with reduced EF and classified them into HF with recovered EF or nonrecovered EF according to whether EF had improved to >40%. DROMs are significantly and independently associated with HF-related events in patients with NIHF. There were no significant differences in DROM and the probability of HF-related events among HF categories in Kaplan-Meier analysis. However, patients with HF with reduced EF and HF with preserved EF but not HF with midrange EF with HF-related events had higher DROM than those without HF-related events. In subgroup analysis, Kaplan-Meier analysis demonstrated that the probabilities of HF-related events in HF with recovered EF were dramatically decreased. DROM were significantly higher in patients with HF with nonrecovered EF than in HF with recovered EF. In receiver operating characteristic analysis, the cutoff level of DROM for predicting improvements in HF with recovered EF was 347 Carratelli units. Furthermore, the C-statistic value for predicting EF improvement for the DROM levels was 0.703. In multivariable logistic regression analysis, DROM was independently and significantly associated with the prediction of HF with recovered EF. Conclusions DROM measurements can provide important prognostic information for risk stratification in any category of NIHF. Registration URL: https://www.umin.ac.jp/ctr/; Unique identifier: UMIN000035827.

摘要

背景

我们研究了活性氧代谢物衍生物(DROMs)这一新型活性氧标志物在非缺血性心力衰竭(HF)患者中的临床意义,并比较了它们在新的 HF 分类中的表现。

方法和结果

我们连续招募了 201 名因 HF 住院的患者,在稳定状态下测量了 DROM。然后,我们根据无冠状动脉疾病的新的 HF 分类(射血分数降低型 HF[HFREF]、射血分数中间值型 HF[HFmrEF]和射血分数保留型 HF[HFpEF])对患者进行分组。在亚组分析中,我们观察了 HFREF 患者的 EF 变化,并根据 EF 是否改善至>40%,将其分为 HFREF 恢复组和非恢复组。

DROM 与 NIHF 患者的 HF 相关事件显著相关且独立相关。在 Kaplan-Meier 分析中,HF 分类之间的 DROM 和 HF 相关事件的概率没有显著差异。然而,HFREF 和 HFpEF 但非 HFmrEF 相关事件的 HF 患者的 DROM 高于无 HF 相关事件的患者。在亚组分析中,Kaplan-Meier 分析表明,HFREF 恢复组的 HF 相关事件概率显著降低。HF 非恢复组的 DROM 明显高于 HF 恢复组。在接受者操作特征分析中,预测 HF 恢复的 DROM 截断值为 347 Carratelli 单位。此外,DROM 水平预测 EF 改善的 C 统计值为 0.703。在多变量逻辑回归分析中,DROM 与 HF 恢复的预测独立且显著相关。

结论

DROM 测量可为 NIHF 的任何类别提供重要的预后信息,用于风险分层。

注册网址

https://www.umin.ac.jp/ctr/;唯一标识符:UMIN000035827。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cdb5/8174381/dca460dda5ff/JAH3-10-e016765-g004.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验